Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing

GlobeNewswire•March 14, 2018 LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing. Bringing more than 35 years of experience, Ruhl will oversee all process development and manufacturing operations. “Steven has a proven track record of building and developing…

Energy Fuels Receives Federal Government Approvals for Expansion of its La Sal Complex of Uranium and Vanadium Mines

PR Newswire•February 26, 2018 LAKEWOOD, CO, Feb. 26, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium in the United States, is pleased to announce that it has received approval from the U.S. Bureau of Land Management (“BLM”) and U.S. Forest Service (“USFS”) for the expansion of its 100%-owned…

Wealth Minerals Provides Corporate Update

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE: WMLCL) (Frankfurt: EJZN), provides a corporate update. Operational Activity Wealth is wrapping up its drilling program at the Laguna Verde project (see press release of December 21, 2017), part of a comprehensive brine evaluation program…

Wealth Strengthens Board with New Appointment

GlobeNewswire•February 14, 2018 VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (WML.V)(WMLLF)(SSE:WMLCL)(EJZN.F), reports that it has strengthened its board of directors with the appointment of Stefan Schauss to serve as a director. “Mr. Schauss brings to Wealth decades of experience in the electric battery, green power…

CURE Pharmaceutical Adds New VP of Strategy and Business Development

Business Wire•January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are starting a pivotal year for CURE, focusing on both…

Wealth Minerals Provides Shareholder Update

December 21, 2017 08:00 ET | Source: Wealth Minerals Ltd. VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN), provides an end of year shareholder update. “We’re very happy to report a year of positive results and steady progress,” states Wealth’s CEO Henk…

Wealth Receives Positive Results from Tenova Advanced Technologies Process Study for the Laguna Verde Project in Chile

Test Work Demonstrates that Tenova Advanced Technologies’ Process Technology can be Successfully Applied to the Laguna Verde Surface Brines November 16, 2017 08:00 ET VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSX-V:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that it has received positive results from its previously…

CURE Pharmaceutical Adds New VP of Strategy and Business Development

CURE Pharmaceutical Adds New VP of Strategy and Business Development January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are…

CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery

OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the company’s mission to support patient needs for better delivery of medication. “Our new branding offers an opportunity to elevate awareness around the challenges patients experience…